Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alphatec Pacific was the Asia-Pacific regional subsidiary of Alphatec Holdings (Alphatec Spine), a medical technology company focused on surgical solutions for spinal disorders. The company provided a comprehensive portfolio of spinal fusion products, including implants and instruments for various surgical approaches such as lateral, posterior, and anterior procedures. Its operations were primarily based in Australia, New Zealand, and Japan, serving as a critical driver for the parent company's international revenue. In 2016, Alphatec Pacific was acquired by Globus Medical as part of an $80 million transaction that included Alphatec's entire international business. This acquisition allowed Globus Medical to transition from a distributor model to a direct sales model in key Pacific markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alphatec Pacific.